JFL Life Sciences Limited (NSE: JFLLIFE)
India
· Delayed Price · Currency is INR 24.65
0.00 (0.00%)
At close: Oct 11, 2024
JFL Life Sciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Revenue | 465.5 | 465.5 | 428.3 | 335.9 | 327.75 | 301.71 | Upgrade
|
| Revenue Growth (YoY) | 8.69% | 8.69% | 27.51% | 2.49% | 8.63% | -5.06% | Upgrade
|
| Cost of Revenue | 388.5 | 388.5 | 346.5 | 258 | 289.3 | 265.4 | Upgrade
|
| Gross Profit | 77 | 77 | 81.8 | 77.9 | 38.45 | 36.32 | Upgrade
|
| Selling, General & Admin | 20.1 | 20.1 | 18.3 | 14.3 | 10.25 | 12.78 | Upgrade
|
| Other Operating Expenses | 11.3 | 11.3 | 24.3 | 10.1 | 6.93 | 5.14 | Upgrade
|
| Operating Expenses | 35.8 | 35.8 | 46.9 | 28.1 | 19.59 | 20.06 | Upgrade
|
| Operating Income | 41.2 | 41.2 | 34.9 | 49.8 | 18.86 | 16.26 | Upgrade
|
| Interest Expense | -8.3 | -8.3 | -14.2 | -20.8 | -12.27 | -11.22 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.79 | 0.22 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 0.08 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.2 | 5.2 | 16.5 | 9 | 0.01 | -0.3 | Upgrade
|
| Pretax Income | 38.1 | 38.1 | 37.2 | 38 | 7.47 | 4.97 | Upgrade
|
| Income Tax Expense | 5 | 5 | 9.1 | 9.9 | 2.05 | 1.37 | Upgrade
|
| Net Income | 33.1 | 33.1 | 28.1 | 28.1 | 5.42 | 3.6 | Upgrade
|
| Net Income to Common | 33.1 | 33.1 | 28.1 | 28.1 | 5.42 | 3.6 | Upgrade
|
| Net Income Growth | 17.79% | 17.79% | 0% | 418.35% | 50.42% | 19.14% | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 29 | 20 | 18 | 16 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 29 | 20 | 18 | 16 | Upgrade
|
| Shares Change (YoY) | 13.50% | 13.50% | 42.06% | 12.44% | 10.33% | 6.82% | Upgrade
|
| EPS (Basic) | 1.00 | 1.00 | 0.97 | 1.37 | 0.30 | 0.22 | Upgrade
|
| EPS (Diluted) | 1.00 | 1.00 | 0.97 | 1.37 | 0.30 | 0.22 | Upgrade
|
| EPS Growth | 3.79% | 3.79% | -29.61% | 362.86% | 35.79% | 11.53% | Upgrade
|
| Free Cash Flow | 22.6 | 22.6 | -90.5 | 6.3 | -75.89 | 4.35 | Upgrade
|
| Free Cash Flow Per Share | 0.69 | 0.69 | -3.11 | 0.31 | -4.17 | 0.26 | Upgrade
|
| Dividend Per Share | 0.083 | 0.083 | - | - | - | - | Upgrade
|
| Gross Margin | 16.54% | 16.54% | 19.10% | 23.19% | 11.73% | 12.04% | Upgrade
|
| Operating Margin | 8.85% | 8.85% | 8.15% | 14.83% | 5.75% | 5.39% | Upgrade
|
| Profit Margin | 7.11% | 7.11% | 6.56% | 8.37% | 1.65% | 1.19% | Upgrade
|
| Free Cash Flow Margin | 4.85% | 4.85% | -21.13% | 1.88% | -23.16% | 1.44% | Upgrade
|
| EBITDA | 45.6 | 45.6 | 39.2 | 53.5 | 21.62 | 18.63 | Upgrade
|
| EBITDA Margin | 9.80% | 9.80% | 9.15% | 15.93% | 6.60% | 6.17% | Upgrade
|
| D&A For EBITDA | 4.4 | 4.4 | 4.3 | 3.7 | 2.76 | 2.37 | Upgrade
|
| EBIT | 41.2 | 41.2 | 34.9 | 49.8 | 18.86 | 16.26 | Upgrade
|
| EBIT Margin | 8.85% | 8.85% | 8.15% | 14.83% | 5.75% | 5.39% | Upgrade
|
| Effective Tax Rate | 13.12% | 13.12% | 24.46% | 26.05% | 27.39% | 27.48% | Upgrade
|
| Revenue as Reported | 470.7 | 470.7 | 444.7 | 344.8 | 328.69 | 302.04 | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.11 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.